Lipoate prevents glucose-induced protein modifications.
Nonenzymatic glycation has been found to increase in a variety of proteins in diabetic patients. The present study examined a possibility of preventing glycation and subsequent structural modifications of proteins by alpha-lipoic acid (thioctic acid) as lipoate, a substance which has gained attention as a potential therapeutic agent for diabetes-induced complications. Incubation of bovine serum albumin (BSA) at 2 mg/ml with glucose (500 mM) in a sterile condition at 37 degrees C for seven days caused glycation and structural modifications of BSA observed by SDS-PAGE, near UV absorption, tryptophan and nontryptophan fluorescence, and fluorescence of an extrinsic probe, TNS (6-(p-toluidinyl)naphthalene-2-sulfonate). When BSA and glucose were incubated in the presence of lipoate (20 mM), glycation and structural modifications of BSA were significantly prevented. Glycation and inactivation of lysozyme were also prevented by lipoate. These results suggest a potential for the therapeutic use of lipoic acid against diabetes-induced complications.
Suzuki
Y J
YJ
Department of Molecular & Cell Biology, University of California, Berkeley 94720.
Tsuchiya
M
M
Packer
L
L
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D005947:Glucose / Q000037:antagonists & inhibitors*; D006031:Glycosylation / Q000187:drug effects; D006801:Humans; D009113:Muramidase / Q000187:drug effects / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000187:drug effects* / Q000378:metabolism; D008063:Thioctic Acid / Q000494:pharmacology*
D012710:Serum Albumin, Bovine; D008063:Thioctic Acid; D009113:Muramidase; D005947:Glucose